In vitro evaluation of α-amylase inhibitory activity of some medicinal plants used in treatment of diabetes mellitus in Algeria and their effect on postprandial hyperglycemia in normal rats

International Journal of Phytomedicine

Volumn 7, Issue 2, 2015, Pages 171-175

  Bechiri, Asma ^a   Chekroun, Echaimaa ^a   Azzi, Rachid ^a   Djaziri, Rabah ^a  

^a UNIVERSITY OF TLEMCEN   (Algeria)

Author keywords

A amylase inhibition; Medicinal plants; Postprandial hyperglycemia; Type 2 diabetes mellitus

Indexed keywords

ACARBOSE; GLUCOSE; JUNIPERUS OXYDRUS EXTRACT; OLEA EUROPEA EXTRACT; PHYLLERIA ANGUSTOFOLIA EXTRACT; PLANT EXTRACT; SALVIA OFFICINALIS EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IC50; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLANT LEAF; RAT; SINGLE DRUG DOSE; SYLVESTRIS;

EID: 84945188625     PISSN: None     EISSN: 09750185     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. [1]. Baron, AD. Postprandial hyperglycaemia and alpha-glucosidase inhibitors. Diabetes Res. Clin. Pract. 1998; 40 (Suppl): 51-55.
2. [2]. Boutati EI, Raptis SA. Post prandial hyperglycemia in type 2diabetes: Pathophysiological aspect, teleogical notions and flags for clinical practice. Diabetes Res. Rev. 2004; 20:13-23
3. [3]. Ceriello A. Cardiovascular effects of acute hypoglycemic pathophysiological under pinnings. Diabetes Vase Dis Res. 2008; 5: 260-268.
4. [4]. Guigliano D, Ceriello A, PaolissoG. Oxydative stress and diabetic vascular complications. Diabetes Care. 1996; 19: 257-267.
5. [5]. Hanefeld M, Cagatay M, Petrowitsch T. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J. 2004; 25(1):10-16.
6. [6]. Mertes G. Safety and efficacy of acarbose in the treatment of Type 2 diabetes: data from 5 years surveillance study. Diab Res Clin Pract. 2001; 2: 193-204.
7. [7]. WHO. Expert committee on diabetes mellitus, 2nd Report. Technical report series: 1980; 646 (9). World Health Organization, Geneva.
8. [8]. Grover JK, Yadav S, Vats V. Medicinal plants of india with antidiabitic potential. J Ethnopharmacol. 2002; 81: 81-100.
9. [9]. Mentreddy SR. Medicinal plant species with potential antidiabetic properties. J Sc Food Agric. 2007; 87(5): 743-750.
10. [10]. Bnouham M, Ziyyat A, Mekhfi H, Tahri A, Legsseyer A. Medicinal plants with potential antidiabetic activity- A review of ten years of herbal medicine research (1990-2000). Int J Diabetes and Metab. 2006; 14: 1-25.
11. [11]. Ali H, Houghton PJ. Alpha amylase inhibitory activity of some Malaysian plants used to treat diabetes, with particular reference to Phyllanthus amarus. J Ethnopharmacol.2006; 107:449-455.
12. [12]. Tarling CA, Woods K, Zhang R, Brastianos HC, Brayer GD, Andersen RJ, Withers SG. The search for novel human pancreatic amylase inhibitors: High-Throughout Screening of Terrestrial and Marine Natural Product Extracts. Chem Bio Chem. 2008; 9: 433-438.
13. [13]. Tundis R, Loizzo MR, Menichini F. Natural products as alpha-amylase and alpha-glucosidase inhibitors and their hypoglycemic potential in the treatment of diabetes:an update. Mini Rev MedChem. 2010; 10(4):315-331.
14. [14]. Sudha PZ, Injarde SP, Bhargava S, Kumar AR. Potent amylase inhibitory activity of Indian Ayurvedic medicinal plants. BMC complementary and alternative medicine. 2011; 11: 5.
15. [15]. Michelle de Sales P, Monteiro de Souza P, Simeoni L, Magalhães PO, Silveira D. Amylase Inhibitors: A Review of Raw Material and Isolated Compounds from Plant Source. J Pharm Pharmaceut Sci. 2012; 15 (1): 141-183.
16. [16]. Tahraoui A, El-Hilaly J, Israili ZH, Lyoussi B. Ethnopharmacological survey of plants used in the traditional treatment of hypertension and diabetes in south-eastern Morocco (Errachidia province). J Ethnopharmacol. 2006; 77: 175-182.
17. [17]. Azzi R, Djaziri R, Lahfa F, Sekkal FZ, Benmehdi H, Belkacem N. Ethnopharmacological survey of medicinal plants used in the traditional treatment of diabetes mellitus in the North Western and South Western Algeria. J Med Plants Res. 2012; 6,10: 2041-2050.
18. [18]. Boudjelal A, Henchiri C, Sari M, Sarri D, Hendel N, Benkhaled A, Ruberto G. Herbalists and wild medicinal plants in M'Sila (North Algeria): An ethnopharmacological survey. J Ethnopharmacol. 2013; 148: 395-02.
19. [19]. Miara MD, Ait Hammou M, Hadjadj Aoul S, Boudjelal A. Phytothérapie et taxonomie des plantes médicinales spontanées dans la région de Tiaret (Algérie). Phytothérapie. 2013; 11: 206-218.
20. [20]. Fakchich J, Elachouri M. Ethnobotanical survey of medicinal plants used by people in Oriental Morocco to manage various ailments. J Ethnopharmacol. 2014; 154 76-87.
21. [21]. Bernfeld P. Amylase and p. Methods enzymol. 1955; 1: 149-158.
22. [22]. Nickavar B, Yousefian N. Evaluation of a-amylase inhibitory activities of selected antidiabetic medicinal plants. J Verbr Lebensm. 2011; 6: 191-195.
23. [23]. Komaki S, Yamaguchi I, Maru M, Kinoshita K, Kakehi Y, Ohta Y, Tsukada Y. Identification of anti-amylase components from olive leafextracts. Food Sci Technol Res. 2003; 9: 35-39.
24. [24]. Kim J, Kwon C, Son K. Inhibition of alpha glucosidase and alpha amylase by luteolin, a flavonoid. Biotechnol Biosci Biochem. 2000; 64: 2458-2461.
25. [25]. Gonzalez M, Zarzuelo A, Gamez MJ, Utrilla MP, Jimenez J, Osuna I. Hypoglycemic activity of olive leaf. Planta Med. 1992; 58: 513-515.
26. [26]. Loizzo MR, Tundis R, Conforli F, Saab AM, Statti AG, Menichini F. Comparative Chemical Composition, antioxidant and hypoglycaemic activities of Junpperus oxydruss spoxydrus L berry and wood oils from Lebanon. Food Chem. 2007; 105:572-578.
27. [27]. Orhan N, Ho ba S, Orhan DD, Aslan M, Ergun F. Enzyme inhibitory and radical scavenging effects of some antidiabetic plants of Turkey. Iran J Basic Med Sci. 2014; 17: 426-432.
28. [28]. Moradabadi L, Montasser Kouhsari S, Fehresti Sani M. Hypoglycemic Effects of Three Medicinal plants in experimental diabetes: Inhibition of rat intestinal -glucosidase and enhanced pancreatic insulin and cardiac Glut-4 mRNAs expression. Iranian J of Pharm Res.2013; 12 (3): 387-397.
29. [29]. Kwon YI, Vattem DA, Shetty K. . Evaluation of clonal herbs of lamiaceae species for management of diabetes and hypertension. Asian Pac J Clin Nutr. 2006; 15: 107-118.
30. [30]. Iman Shahidi M, Hosseinzadeh H. Review the pharmacological effects of salvia species on the central nervous system. Phyto Res. 2006; 20: 427-437.
31. [31]. Eidi M, Eidi A, Zamanizadeh H. Effect of Salvia officinalis L. leaves on serum glucose and insulin in healthy and streptozocin-induced diabetic rats. J Ethnopharmacol. 2005; 100: 310-313.
32. [32]. Lima CF, Azevedo MF, Araujo R, Fernandes-Ferreira M, Pereira-Wilson C. Metformine-like effect of Salvia officinalis (common sage): is it useful in diabetes prevention. Br J Nutr. 2006; 96: 326-333.
33. [33]. Kianbakhta S, Hashem Dabaghian F., Improved glycemic control and lipid profile in hyperlipidemic type2 diabetic patients consuming Salvia officinalis L. leaf extract: A randomized placebo: Controlled clinical Trial. Compl Ther in Med.2013; 21: 441-446.
34. [34]. El-Mokasabi Farag M. Floristic composition and traditional uses of plant species at WadiAlkuf, Al-jabal Al-akhder, Libya. Am-eurasian J Agric Envir Sci. 2014; 14(8): 685-697.
35. [35]. Eddouks M, Maghrani M, Lemhadri A, Ouahidi ML, Jouad H. Ethnopharmacological survey of medicinal plants used for the treatment of diabetes mellitus, hypertension and cardiac diseases in the south-east region of Morocco (Tafilalet). J Ethnopharmacol. 2002; 82: 97-103.